Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters











Database
Language
Publication year range
1.
Mucosal Immunol ; 11(1): 97-111, 2018 01.
Article in English | MEDLINE | ID: mdl-28401936

ABSTRACT

Patients with asthma experience circadian variations in their symptoms. However it remains unclear how specific aspects of this common airway disease relate to clock genes, which are critical to the generation of circadian rhythms in mammals. Here, we used a viral model of acute and chronic airway disease to examine how circadian clock disruption affects asthmatic lung phenotypes. Deletion of the core clock gene bmal1 or environmental disruption of circadian function by jet lag exacerbated acute viral bronchiolitis caused by Sendai virus (SeV) and influenza A virus in mice. Post-natal deletion of bmal1 was sufficient to trigger increased SeV susceptibility and correlated with impaired control of viral replication. Importantly, bmal1-/- mice developed much more extensive asthma-like airway changes post infection, including mucus production and increased airway resistance. In human airway samples from two asthma cohorts, we observed altered expression patterns of multiple clock genes. Our results suggest a role for bmal1 in the development of asthmatic airway disease via the regulation of lung antiviral responses to common viral triggers of asthma.


Subject(s)
ARNTL Transcription Factors/genetics , Asthma/immunology , Bronchiolitis, Viral/immunology , Circadian Clocks/genetics , Influenza A virus/physiology , Orthomyxoviridae Infections/immunology , Respirovirus Infections/immunology , Sendai virus/immunology , ARNTL Transcription Factors/metabolism , Airway Remodeling/genetics , Airway Resistance/genetics , Animals , Cohort Studies , Disease Models, Animal , Humans , Mice , Mice, Knockout , Mucus/metabolism , Virus Replication
2.
Curr Opin Allergy Clin Immunol ; 17(2): 139-145, 2017 Apr.
Article in English | MEDLINE | ID: mdl-28079559

ABSTRACT

PURPOSE OF REVIEW: Asthma exhibits significant heterogeneity in occurrence and severity over the lifespan. Our goal is to discuss recent evidence regarding determinants of the natural history of asthma during childhood, and review the rationale behind and status of major efforts to alter its course. RECENT FINDINGS: Variations in microbial exposures are associated with risk of allergic disease, and the use of bacterial lysates may be a promising preventive strategy. Exposure to air pollution appears to be particularly damaging in prenatal and early life, and interventions to reduce pollution are feasible and result in clinical benefit. E-cigarette use may have a role in harm reduction for conventional cigarette smokers with asthma, but has undefined short-term and long-term effects that must be clarified. Vitamin D insufficiency over the first several years of life is associated with risk of asthma, and vitamin D supplementation reduces the risk of severe exacerbations. SUMMARY: The identification of risk factors for asthma occurrence, persistence and severity will continue to guide efforts to alter the natural history of the disease. We have reviewed several promising strategies that are currently under investigation. Vitamin D supplementation and air pollution reduction have been shown to be effective strategies and warrant increased investigation and implementation.


Subject(s)
Asthma/epidemiology , Bacterial Infections/epidemiology , Prenatal Exposure Delayed Effects/epidemiology , Air Pollution/adverse effects , Animals , Asthma/prevention & control , Child , Electronic Nicotine Delivery Systems , Environmental Exposure/adverse effects , Female , Humans , Maternal Exposure/adverse effects , Pregnancy , Prenatal Exposure Delayed Effects/prevention & control , Risk , Smoking/adverse effects , Vitamin D
3.
Clin Exp Allergy ; 45(12): 1856-67, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26414909

ABSTRACT

BACKGROUND AND OBJECTIVE: The allergenicity of several German cockroach (Bla-g) antigens at the level of IgE responses is well established. However, less is known about the specificity of CD4+ TH responses, and whether differences exist in associated magnitude or cytokine profiles as a function of disease severity. METHODS: Proteomic and transcriptomic techniques were used to identify novel antigens recognized by allergen-specific T cells. To characterize different TH functionalities of allergen-specific T cells, ELISPOT assays with sets of overlapping peptides covering the sequences of known allergens and novel antigens were employed to measure release of IL-5, IFNγ, IL-10, IL-17 and IL-21. RESULTS: Using these techniques, we characterized TH responses in a cohort of adult Bla-g-sensitized subjects, either with (n = 55) or without (n = 17) asthma, and nonsensitized controls (n = 20). T cell responses were detected for ten known Bla-g allergens and an additional ten novel Bla-g antigens, representing in total a 5-fold increase in the number of antigens demonstrated to be targeted by allergen-specific T cells. Responses of sensitized individuals regardless of asthma status were predominantly TH 2, but higher in patients with diagnosed asthma. In asthmatic subjects, Bla-g 5, 9 and 11 were immunodominant, while, in contrast, nonasthmatic-sensitized subjects responded mostly to Bla-g 5 and 4 and the novel antigen NBGA5. CONCLUSIONS: Asthmatic and nonasthmatic cockroach-sensitized individuals exhibit similar TH 2-polarized responses. Compared with nonasthmatics, however, asthmatic individuals have responses of higher magnitude and different allergen specificity.


Subject(s)
Allergens/immunology , Asthma/immunology , Blattellidae/immunology , Epitopes, T-Lymphocyte/immunology , Rhinitis/immunology , T-Lymphocyte Subsets/immunology , Adult , Animals , Antigen Presentation , Asthma/metabolism , Blattellidae/genetics , Blattellidae/metabolism , Case-Control Studies , Epitope Mapping , Epitopes, T-Lymphocyte/chemistry , Epitopes, T-Lymphocyte/metabolism , Female , Histocompatibility Antigens Class II/immunology , Humans , Immunization , Immunodominant Epitopes/chemistry , Immunodominant Epitopes/immunology , Leukocytes, Mononuclear/immunology , Leukocytes, Mononuclear/metabolism , Male , Middle Aged , Peptides/chemistry , Peptides/immunology , Peptides/metabolism , Rhinitis/metabolism , T-Lymphocyte Subsets/metabolism , Young Adult
4.
Allergy ; 67(8): 976-97, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22702533

ABSTRACT

Asthma is the most common chronic lower respiratory disease in childhood throughout the world. Several guidelines and/or consensus documents are available to support medical decisions on pediatric asthma. Although there is no doubt that the use of common systematic approaches for management can considerably improve outcomes, dissemination and implementation of these are still major challenges. Consequently, the International Collaboration in Asthma, Allergy and Immunology (iCAALL), recently formed by the EAACI, AAAAI, ACAAI, and WAO, has decided to propose an International Consensus on (ICON) Pediatric Asthma. The purpose of this document is to highlight the key messages that are common to many of the existing guidelines, while critically reviewing and commenting on any differences, thus providing a concise reference. The principles of pediatric asthma management are generally accepted. Overall, the treatment goal is disease control. To achieve this, patients and their parents should be educated to optimally manage the disease, in collaboration with healthcare professionals. Identification and avoidance of triggers is also of significant importance. Assessment and monitoring should be performed regularly to re-evaluate and fine-tune treatment. Pharmacotherapy is the cornerstone of treatment. The optimal use of medication can, in most cases, help patients control symptoms and reduce the risk for future morbidity. The management of exacerbations is a major consideration, independent of chronic treatment. There is a trend toward considering phenotype-specific treatment choices; however, this goal has not yet been achieved.


Subject(s)
Asthma/diagnosis , Asthma/therapy , Adolescent , Asthma/classification , Asthma/prevention & control , Child , Child, Preschool , Humans , Infant , Infant, Newborn
5.
Allergy ; 63(1): 5-34, 2008 Jan.
Article in English | MEDLINE | ID: mdl-18053013

ABSTRACT

Asthma is the leading chronic disease among children in most industrialized countries. However, the evidence base on specific aspects of pediatric asthma, including therapeutic strategies, is limited and no recent international guidelines have focused exclusively on pediatric asthma. As a result, the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma and Immunology nominated expert teams to find a consensus to serve as a guideline for clinical practice in Europe as well as in North America. This consensus report recommends strategies that include pharmacological treatment, allergen and trigger avoidance and asthma education. The report is part of the PRACTALL initiative, which is endorsed by both academies.


Subject(s)
Asthma/diagnosis , Asthma/therapy , Practice Guidelines as Topic/standards , Child , Child, Preschool , Europe , Female , Humans , Male , United States
6.
J Allergy Clin Immunol ; 105(2 Pt 2): S547-58, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10669540

ABSTRACT

IgE antibody plays an important role in allergic diseases. IgE synthesis by B cells requires two signals. The first signal is delivered by the cytokines IL-4 or IL-13, which target the Cepsilon gene for switch recombination. The second signal is delivered by interaction of the B cell surface antigen CD40 with its ligand (CD40L) expressed on activated T cells. This activates deletional switch recombination. We review the molecular mechanisms of IL-4 and CD40 signaling that lead to IgE isotype switching and discuss the implications for intervening to abort or suppress the IgE antibody response.


Subject(s)
B-Lymphocytes/physiology , Gene Rearrangement , Immunoglobulin E/physiology , Animals , CD40 Antigens/metabolism , CD40 Antigens/physiology , CD40 Ligand , Humans , Immunoglobulin E/metabolism , Interleukin-13/physiology , Interleukin-4/physiology , Membrane Glycoproteins/metabolism , Models, Biological , Signal Transduction , T-Lymphocytes/physiology
7.
Immunity ; 11(3): 339-48, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10514012

ABSTRACT

CD40 plays a critical role in survival, growth, differentiation, and class switching of B lymphocytes. Although Ku is required for immunoglobulin class switching, how CD40 signal transduction is coupled to Ku is still unknown. Here, we show that CD40 directly interacts with Ku through the membrane-proximal region of cytoplasmic CD40. Ku was confined to the cytoplasm in human primary B cells, and the engagement of CD40 on the B cells cultured in the presence of IL-4 resulted in the dissociation of Ku from CD40, translocation of Ku into the nucleus, and increase in the activity of DNA-dependent protein kinase. These findings indicate that Ku is involved in the CD40 signal transduction pathway and may play an important role in the CD40-mediated events.


Subject(s)
Antigens, Nuclear , B-Lymphocytes/metabolism , CD40 Antigens/metabolism , DNA Helicases , DNA-Binding Proteins/metabolism , Interleukin-4/metabolism , Nuclear Proteins/metabolism , Antibodies, Monoclonal , B-Lymphocytes/drug effects , Biological Transport , CD40 Antigens/immunology , Cell Membrane/metabolism , Cell Nucleus/metabolism , Cells, Cultured , Cytoplasm/metabolism , DNA-Activated Protein Kinase , Humans , Immunoglobulin Class Switching , Interleukin-4/pharmacology , Intracellular Fluid/metabolism , Ku Autoantigen , Lysine/metabolism , Phosphorylation , Proline/metabolism , Protein Serine-Threonine Kinases/metabolism , Tumor Cells, Cultured , Tyrosine/metabolism , Up-Regulation
8.
Allergy Asthma Proc ; 20(1): 1-8, 1999.
Article in English | MEDLINE | ID: mdl-10076703

ABSTRACT

The reagenic antibody in the sera of atopic individuals, first described by Prausnitz and Kustner and later determined to be Immunoglobulin (Ig) E by the Ishizakas, plays a critical role in the pathogenesis of allergic disease. Investigation into the cellular basis of IgE regulation has provided important insights into a disease process that affects up to 30% of the population world-wide. Over the last decade, the molecular events regulating IgE synthesis have been actively investigated. In this review, we will discuss the various components of this system including the cells, cytokines, signal transduction events, and molecular mechanisms that participate in human IgE synthesis and explore rational therapeutic approaches directed at the modulation of these systems.


Subject(s)
Hypersensitivity, Immediate/immunology , Immunity, Cellular/physiology , Immunoglobulin E/biosynthesis , Anti-Allergic Agents/administration & dosage , Cytokines/metabolism , Humans , Hypersensitivity, Immediate/drug therapy , Immunoglobulin E/drug effects , Molecular Biology , Signal Transduction
SELECTION OF CITATIONS
SEARCH DETAIL